Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives

Carcinosarcomas (CS) in gynecology are very infrequent and represent only 2–5% of uterine cancers. Despite surgical cytoreduction and subsequent chemotherapy being the primary treatment for uterine CS, the overall five-year survival rate is 30 ± 9% and recurrence is extremely common (50–80%). Due to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Vitale, Salvatore Giovanni, Laganà, Antonio Simone, Capriglione, Stella, Angioli, Roberto, La Rosa, Valentina Lucia, Lopez, Salvatore, Valenti, Gaetano, Sapia, Fabrizio, Sarpietro, Giuseppe, Butticè, Salvatore, Tuscano, Carmelo, Fanale, Daniele, Tropea, Alessandro, Rossetti, Diego
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2017
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455008/
https://ncbi.nlm.nih.gov/pubmed/28531111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18051100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados